[Event Report] Mental Health Policy Project Examines Best Direction for Promoting Effective Technology Use from the Perspectives of Those Most Affected in First Roundtable on “Policy Issues and Next Steps for Better Mental Health Through Mental Healthtech” (September 1, 2022)
date : 12/9/2022
Tags: Mental Health
![[Event Report] Mental Health Policy Project Examines Best Direction for Promoting Effective Technology Use from the Perspectives of Those Most Affected in First Roundtable on “Policy Issues and Next Steps for Better Mental Health Through Mental Healthtech” (September 1, 2022)](https://hgpi.org/en/wp-content/uploads/sites/2/e7c09cfdbf7beb124723602eda9b36bd.jpg)
*A summary of the roundtable discussion has been published. (December 9, 2022)
On September 1, 2022, the Health and Global Policy Institute (HGPI) Mental Health Policy Project hosted the first roundtable discussion for an initiative titled “Policy Issues and Next Steps for Better Mental Health Through Mental Healthtech.” The meeting was held online and was not open to the public.
The HGPI Mental Health Policy Project was launched in FY2019 with the belief that mental health policy encompasses the stages of mental illnesses and disorders that require continuous support from professionals in medical, health, and welfare services and mental health challenges that can make life feel like a minor yet constant struggle. Based on this thinking, we believe uniting multi-stakeholders centered around those most affected to build a system that provides seamless support along the life course will be crucial in future mental health policy. With the ultimate goal of improving quality of life (QOL) through better mental health for every member of society, we have continuously issued recommendations and have taken action for policy reform in this area.
To promote a comprehensive life course approach to mental health that includes perspectives on health promotion as well as to encourage people to act on mental health issues before their condition progresses to the point they require treatment, establishing an environment in which each individual can manage their own mental health will be essential. To help create such an environment, expectations are high for the effective use of digital technology in the field of mental health.
A broad variety of digital tools have the potential to contribute in this field. They not only include self-care tools and tools designed to provide therapeutic effects called “programmed medical devices,” but also include tools used for data collection and analysis. It is difficult to say that a major direction for policy in this area has been set. Above all, we must hold multi-faceted discussions on the benefits and disadvantages of utilizing digital technology from the perspectives of the patients and affected parties who will be using it. Those discussions must explore best methods of assessing the quality of digital technology, examine accessibility, and consider information security and other ethical aspects of utilizing digital technology.
Given these circumstances, this roundtable discussion focused on the topic of mental healthtech for self-care and health promotion. We joined people affected by mental health issues; representatives of academia and industry, who are responsible for developing technology and building evidence; Government representatives; and other multi-stakeholders to examine current issues and necessary measures from the following perspectives:
- How can people choose the mental healthtech that they need?
- What should people do when they require treatment?
- What evidence will be required of mental healthtech?
- Who will bear the cost of prevention and health promotion?
Roundtable discussion participants (titles omitted; in Japanese syllabary order)
- Yasushi Ochiai (Development Planning Officer, Frontier Business Office, Sumitomo Pharma Co., Ltd.)
- Kensuke Kaneko (Representative Director and Managing Executive Officer, KANEKOSHOBO)
- Hironori Kuga (Director, National Center for Cognitive Behavior Therapy and Research, National Center of Neurology and Psychiatry)
- Keigo Kobayashi (Person Living With a Mental Disorder)
- Tomoya Koyama (Deputy Director, Healthcare Industries Division, Commerce and Service Industry Policy Group, Ministry of Economy, Trade and Industry (METI))
- Daiki Takegawa (Chief Operations Officer and Representative Director, emol Co. Ltd.)
- Yoshitake Takebayashi (Associate Professor, Department of Health Risk Communication, School of Medicine, Fukushima Medical University)
- Shingo Hayashi (Person Living With a Mental Disorder; Representative Director, Beta Trip Co. Ltd.)
- Takashi Mihara (Head Researcher, NLI Research Institute)
- Masako Mizumachi (Attorney at Law, Miyauchi & Mizumachi IT Law Firm)
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Public Comment Submission] “GX2040 Vision (Draft)” (January 26, 2025)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Public Comment Submission] “Third Phase of The Healthcare Policy (Draft)” (February 3, 2025)
- [Public Comment Submission] “Plan for Global Warming Countermeasures (Draft)” (January 26, 2025)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Achieving a Sustainable Society of Health and Longevity Through the Integration of Environment and Healthcare-Incorporating a Planetary Health Perspective into the 3rd Phase of The Healthcare Policy-(December 20, 2024)
Featured Posts
-
2025-02-12
[Registration Open] (Webinar) The 131st HGPI Seminar “The Policy Process of the Kyoto City Caregiver Ordinance” (March 19, 2025)
-
2025-02-20
[Registration Open] The Cardiovascular Disease (CVD) Control Promotion Project Online Global Symposium “Exploring the Future of CVD Control Through Policy Case Studies in the Asia-Pacific Region” (March 13, 2025)
-
2025-03-03
[Registration Open] (Webinar) HGPI Special Seminar “Insights from Harvard Students on Fukushima’s Recover” (March 21, 2025 EDT | March 22, 2025 JST)
-
2025-03-13
[HGPI Policy Column] (No.54) From the Kidney Disease Control Promotion Project “The Promotion of Kidney Disease Measures Through Multi-Stakeholder Collaboration”
-
2025-03-13
[HGPI Policy Column] (No.55) From the Kidney Disease Control Promotion Project “What Is Required from a Patient Perspective for Continuity of Treatment for Chronic Kidney Disease (CKD): Dietary Therapy Edition”